AliveCor has received clearance for its portable ECG to calculate a patient’s QTc Interval. This FDA action follows the enforcement policy for non-invasive devices issued by the agency in March 2020 ...
Copenhagen, Denmark - A team of Danish researchers have shown that certain patients with congestive heart failure (CHF) may benefit from the class III antiarrhythmic drug dofetilide (Tikosyn? - Pfizer ...
Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results